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"Informed consent" sets a goal for investigators experimenting with human subjects, but lit-
tle is known about how to achieve or evaluate it in an experiment. In a 3-year, double-blind
study with incarcerated men, we attempted to provide a "free and informed consent" and
evaluated our efforts with an unannounced questionnaire administered to subjects after they
completed the experiment. At that time, approximately two-thirds had sufficient information
for an informed consent, but only one-third was well informed about all key aspects of the ex-
periment and one-third was insufficiently informed to give an informed consent. We found that
institution- or study-based coercion was minimal in our experiment. From our evaluation ofthe
questionnaire and experience at the study institution, we conclude that an experiment with
human subjects should be designed to include an ongoing evaluation of informed consent, and
active attempts should be made to avoid or minimize coercive inducements. Experiments with
significant risk, which require a long duration and/or large sample size relative to the institu-
tion's population, should probably not be performed on prisoner subjects. The experimenter
should be independent of the penal institution's power structure. Presenting and explaining a
consent form to volunteers on one occasion is probably an inadequate procedure for obtaining
and maintaining an informed consent.
INTRODUCTION
Until recently, scrutiny of experiments involving human subjects was made princi-
pally by investigators who focused on questions of methodology, i.e., data reliability
and reproducibility, rather than questions ofethics. As a result, the ethical problems
ofprotection ofhuman subjects have been neglected compared to the methodological
problems, and the principal source ofexperience drawn upon in the current examina-
tion of research ethics, and for guidelines for human experimentation (1), has been
the common law regulating physician-patient relationships (2). The ideas about re-
search ethics which have resulted are summarized in the concept of informed
consent, which establishes criteria for the protection of the experimental subject.
Key aspects ofinformed consent are that the subject is aware he is participating in an
experiment and knows its objects or goals; that he understands the risks and benefits
ofhis participation; and that he is neither forced to participate nor subject to punish-
ment for withdrawal ofhis participation.
Prisoners are frequently employed as subjects of pharmacological and other ex-
periments and are especially vulnerable to coercion and limited information. The
possibility of achieving a "free and informed consent" in prisoner research has been
denied by some observers, who assert that the nature ofa penal institution inevitably
compromises informed consent (3). Others stress that a researcher must understand
the unique institutional and personal factors influencing prisoners (4-6) and have sug-
gested that investigators who are aware of and sensitive to these factors can provide
the basis for a free and informed consent (4,5). Evidence and opinion on ethical and
legal aspects of prison research has been outlined effectively by Katz (7), and im-
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portant aspects of motivations and rewards for prisoner subjects are discussed by
Ayd (8).
In this paper we report the results of our evaluation of informed consent in a 3-
year study of the antiaggressive effect of lithium carbonate (9), conducted with
inmates of the principal Connecticut Correctional Institution for men under 21 years
of age. The results and conclusions are based on our observations during the study
and on answers to a questionnaire routinely given to subjects upon termination ofthe
experiment. The unannounced questionnaire contained 11 simply phrased questions
dealing with issues we viewed as relevant to informed consent.
The evaluation was prompted by the controversy about informed consent with
prisoner subjects, which emphasizes the need for information based on actual
experience with the problems of conducting research in prisons. We hope this study
will help clarify some problems of informed consent with captive subjects and will aid
other investigators in designing ongoing evaluations of informed consent within their
primary research objectives.
DESCRIPTION OF LITHIUM EXPERIMENT
The experiment was designed to compare the effect of lithium carbonate versus
placebo in modifying the frequency of threatening or violent behavior and/or reduc-
ing angry affect in a heterogeneous group ofincarcerated male delinquents (9). It was
an outgrowth of work on the modification ofviolent behavior by lithium in chronically
assaultive men reported by Sheard (10,11) and confirmed by others (12).
The experiment operated on a 5-month regime: a drug-free control month,
followed by up to 3 months with single daily doses of either sustained-release lithium
carbonate (Priadel) or identical-appearing placebo administered under double-blind
conditions, and concluded with a drug-free control month. During medication, blood
samples were obtained weekly for serum lithium levels and clinical tests (13). Sub-
jects continued with their usual institutional routine, except for the 0.5 to 2 hr per
week during which they performed study tasks; they received no privileges or ame-
nities within the institution. Subjects were paid at the rate of $3.75 per week, whether
or not they completed the experiment. Those who completed or whose termination
was beyond their control (e.g., transfer to another institution) received a bonus of
$2.50 per week (gross rate of pay, $6.25 per week, for a maximum payment of
$125.00 for 5 months). The pay rate was equivalent to monthly remuneration for the
best-paying inmate jobs at the study institution during our experiment (October
1972-June 1975).
All subjects signed consent forms and an identical form was also signed by a
parent or the legal guardian of subjects under 18 years old. The consent form was as
follows.
The purpose of this project is to test whether lithium (which is a simple chemical element) can
help the control of impulsive and aggressive behavior. This is why you have been asked to
volunteer. In order to see if lithium has any good effects it is necessary to compare it with a
placebo (a substance which works by suggestion only). You will not know which of the two agents
you are getting. You may notice symptoms such as nausea, hand tremors, headaches, diarrhea,
constipation, or dryness of the mouth, which we will try to avoid as much as possible, and can
treat early if they occur. Repeated clinical interviews, psychological behavioral testing and a
weekly blood test will be performed to follow your progress. Should there be any indication that
it is not in your best interest to continue the treatment, the medicinewill be discontinued. You
are free to discontinue the trial should you wish to do so, and there will be no penalty to you for so
doing. Participation in this experimental treatment program will not influence your status in the
correctional institution.
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Criteria of acceptability for the experiment were: (i) conviction for a serious
assaultive crime (e.g., manslaughter, murder, rape, assault); a history of chronic
assaultive behavior; or a history ofchronic impulsive antisocial behavior; (ii) freedom
from psychosis; (iii) good physical health with absence ofillness contraindicating lit-
hium treatment; (iv) ability to comprehend the written material used in the study; (v)
sentence of sufficient duration to insure time for completion of the study. Subjects
taking psychoactive medication (e.g., tranquilizers) were not accepted for the
program unless medication was discontinued with the consent ofthe prescribing phy-
sician. All subjects accepted for the study were given a physical examination before
receiving medication.
Inmates were referred to the experiment by the institutional counseling staff, to
whom we had described the experiment and admissions criteria. On interview, the
study was described, and a referral's suitability was determined by a staff psychia-
trist and the senior investigator. Subjects were not given the consent form until they
had 2-4 weeks of contact with the study staff and had received a detailed explanation
of the program. All staff members who had contact with the subjects were blind to
the medication for the duration ofthe experiment (9, 14).
SUBJECTS AND INFORMED CONSENT QUESTIONNAIRE
The men reported on here (N = 58) received the questionnaire on informed
consent when they left the study. There was no other criterion for selection of these
subjects. Of this group, 44 (76%) completed the entire study, 10 (17%) quit, 2 (3.5%)
were dropped for noncooperation, and 2 were lost due to transfer. The sample
represents 67% of all subjects who completed the study and 55% of all subjects who
quit. Average age 1 month before receiving medication was 19.1 years; average voca-
bulary-based IQ (15) was 90.0; average Memory-For-Designs brain damage score
(16) was 2.8 (normal range: 0-4); 34 subjects (58.6%) were white, 19 (32.8%) black,
and 5 (8.6%) Hispanic. Thirty-five (62.5%) received lithium carbonate and 21 (37.5%)
received placebo; 2 subjects had received no medication when they left the study.
Thirty-nine (67.2%) had been arrested and/or convicted for a crime ofviolence.
The questionnaire, which was not anonymous, was administered to each subject at
his final staff contact; a staff member was available to offer assistance to subjects
with poor verbal skills. An analysis of response in terms of drug and status (com-
plete, quit, etc.) would not have been possible with an anonymous questionnaire. The
directions were: "This is not a test. We want to know your answers so we can
improve the Program. Answer every question that applies to you. If you don't know
how to spell a name, write in what sounds right to you." All subjects had received
partial or complete payment from the study and were aware that remuneration was
not in jeopardy when they got the questionnaire. Since subjects were interviewed
after completing the study, and since our staff members had no authority to impose
institutional punishments and had no poststudy commitments, we feel that the sub-
jects answered candidly. In scoring, ambiguities due to the limited language skills of
many subjects were taken into consideration. Because a staff member was available
to answer questions during completion of the questionnaire, we believe all subjects
understood the questionnaire items. Staff members never hinted at answers or pro-
vided information which would influence subjects' responses.
INFORMATION FOR THE VOLUNTEER SUBJECTS
In part, informed consent establishes criteria for informing the subjects about par-
ticipation in an experiment. To evaluate this aspect of informed consent, we must
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compare the output (answers on questionnaire) with the input (routine study in-
formation). Our standard format, presented by the same staffmember in a reprodu-
cible manner throughout the study, was as follows.
All referrals received a detailed presentation within their first 2 weeks with the ex-
periment, generally during their first staffcontact. Each was given a printed descrip-
tion ofthe study which included its purpose, the age and medication requirements, an
outline of the experiment, the names of the drugs involved, the requirement ofblood
samples, and the payment schedule. This was always supplemented with a 0.5-1-hr
oral presentation.
The oral presentation stressed that the study was experimental and was not a
treatment program. Lithium carbonate was described, as was its history in the treat-
ment of manic-depressive illness and its availability by prescription (to stress that
the drug itself was not experimental). The pilot use oflithium in the treatment ofag-
gressive behavior was outlined and the subject told that, while we felt lithium did help
some men control aggressive behavior, we knew that it did not help all men; the pur-
pose of the experiment was to prove whether or not it worked, and with whom. We
stressed that we could therefore not promise any benefits related to the drug. The
placebo effect was discussed as well as the reasons for a double-blind design. It was
made clear that neither our staffat thejail nor the subject would know which drug he
received, and because of the double-blind we could not guarantee that a subject
would receive lithium even ifhe wanted to try the medication to improve his behavior.
We asserted that the only benefits we could be sure of were remuneration, an op-
portunity to have a change of routine, and contact with noninstitutional people. It
was stressed that we were neither part of thejail staffnor affiliated with the Depart-
ment ofCorrections.
Each subject was assured that his records would be kept strictly confidential and
was told that we made no poststudy commitments and refused to be involved in
parole or probationary considerations. We discussed payment, pointing out explicitly
that money was paid for weeks completed, with a bonus for completion of the full
program, which meant that quitting would result in reduced remuneration and that
this was the only penalty for quitting the experiment. We stressed that the subject
was free to terminate at any time.
We described side effects, pointing out that because of the placebo effect subjects
might experience side effects on either lithium or placebo, but that symptoms were
more likely, and longer lasting, with lithium. Subjects were told that no one
experiences all the side effects and some subjects would experience none, and the
purpose and necessity of the weekly blood sample were explained. Side effects
described included headache, loss ofappetite, thirst, dryness ofmouth, increased uri-
nary frequency, hand tremor, and gastrointestinal disturbances; a description was
given in words familiar to the subject. In addition to this presentation ofside effects,
each subject completed a weekly symptom check list which included the symptoms
described above (13).
The possibility of lithium intoxication ("overdose") with symptoms of increased
tremor, stumbling and loss ofcoordination, confusion and stupor was mentioned, but
it was stressed that taking weekly blood samples would greatly minimize the possi-
bility of intoxication and that intoxication and unpleasant side effects could be dealt
with by reducing dose or stopping medication. We concluded by encouraging the sub-
ject to question the staff about matters of concern or interest to him throughout the
study.
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RESULTS
The summarized results for all subjects are presented in Table 1 in which the ques-
tions are given as they appeared on the questionnaire. To evaluate our subjects'
comprehension ofthe key aspects ofthe experiment, we examine answers to the first
six questions in Table 1. A total of 18 subjects (31.6%) answered all Questions 1-6
completely and correctly. Virtually all (97%) knew that lithium (carbonate) was the
drug being tested and virtually all (98%) were aware of the correct payment. Most
(82%) knew that lithium and a placebo ("sugar pill") were the two drugs available (an
additional 5 subjects (9%) named one ofthese). The two subjects who did not give the
name of the study drug deserve comment. Both answered very few questions (3/11
for a subject who was dropped and 6/11 for a subject who quit), and it is probable
that, had they been more motivated to respond, they would have given the correct
answer. This follows from the fact that our experiment was known for nearly three
years at the host institution as the "Lithium Program," so that the name of the
medication we studied was known to nearly all inmates and staff, as we had intended.
Question 2 gives an opportunity to evaluate the subjects' understanding of their
role in the study and its purpose. Most of the subjects (71%) gave an answer which
clearly indicated the experimental nature of the study: "to experiment the drug (sic)
with different types of people" and "to find out if the drug can work on violent
TABLE 1
Responses to Informed Consent Questionnaire
Total
Question answers Responses [N(%)]
Correct Incorrect
1. What is the name ofthe drug we
are testing?
2. What is the purpose of
this program?
3. How much does the program pay?
4. Why do we take blood samples?
5. What are some side effects from
this drug? (Drug in Question 1)
6. Ifyou got medication every day,
you got one of two possible drugs.
What are their names?
7. Why did you volunteer for this
program?
8. Did you feel forced tojoin the
program? If you did, how?
9. Did the program do you any
good? Ifit did, how?
10. Did the program do you any
harm? If it did, how?
11. Do you think we were honest
about the program?
58
59
57
56
56
None
57 20(35.1)
56(96.6) 2(3.4)
(Experimental)
42(71.2) 17(28.8)
(Aggression)
27(47.4) 30(52.6)
55(98.2) 1(1.8)
34(60.7) 22(39.0)
Correct side effects named
One Two Three or more
10(17.5) 16(28.1) 11(19.3)
Correct drugs named
None One
54 5(9.26) 5(9.26)
Money Self-help Miscellaneous
64 27(42.2) 22(34.4) 12(18.8)
Yes No
56 1(1.8) 55(98.2)
56 32(56.1)
57 14(24.6)
18(31.6)
41(71.9)
Two
44(81.5)
Parole
3(4.69)
?
0(0)
7(12.3)
2(3.5)
4(7.3) 5(9.1)
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people" are typical. However, nine men (15%) gave no indication of an experiment
and eight (13.5%) simply said they did not know the purpose ofthe study.
Only 47% ofthe subjects indicated the importanceofaggressive behavior in the ex-
periment. A good answer was "to experiment w(ith) lithium to see if it controls vio-
lent or other types of behavior related to violence." A more typical answer was "to
detumen wheather (sic) or not it (lithium) can help level a person's temper off." A
typical answer not indicating aggression was "to try to find out how lithium helps
people." That only halfof the subjects indicated aggression is unexpected since our
experiment had a reputation in the institution for selecting violence-prone men as
shown by inmates who approached staff members in the corridors with advertise-
ments of aggressive prowess. Also, the study explicitly investigated aggressive be-
havior in terms ofboth admissions criteria and routine weekly questions about violent
behavior.
A majority of subjects (61%) correctly indicated that the blood sample was re-
quired to monitor lithium levels in the blood. Typical incorrect answers suggested
prior experience with drug abuse programs: "to make sure I didn't take any other
drugs"; "to make sure were taken (sic) the lithium."
With regard to side effects, 65% gave at least one correct side effect ofthe medica-
tion as described by the staff, but only 19% could give three or more, and 35% gave
no correct side effects (although many subjects reported symptoms they had
experienced while on the study). Most common side effects given were shakiness or
tremor (N = 14), headache (N = 13), and stomach cramps or pains (N = 8) (13).
To evaluate motivation, we consider Question 7. The largest group of responses
(42% of total) indicated money; 34% indicated self-improvement, and only 4.7%
(3 subjects) gave help at the parole board as a consideration. The remainder of
responses (19%) indicated interest in the study (N = 6), chance ofgetting high (N =
2), seeing psychiatrist (N = 1), and variety (N = 1) as reasons forjoining.
Questions 8-11 give the subjects' evaluation of the study. Virtually all (96%)
denied that they "felt forced" to join, and a large majority (84%) said that the staff
had been honest; 7% felt we had been dishonest, and 9% were unsure, usually be-
cause they were concerned with long-term effects of the medication which could not
be evaluated at the time they received the questionnaire. Over half (56%) felt that
they received benefits. Of these men, 29 (94%) gave reasons. Increased self-
knowledge or self-control (most frequently expressed as "slowed me down some")
accounted for 20 of the responses (69%); contact with staff for 5 (17%), increased
knowlege for 2 (7%), and money for 2. Nearly 25% of the subjects reported that the
study did them some harm, 4% were unsure, and 72% reported they were not
harmed. All the subjects (N = 14) who felt harmed gave reasons: 12 were side
effects, and 2 were adverse (paradoxical) effects on behavior. Half of the subjects
who felt harmed quit the experiment.
Table 2 compares study completers and noncompleters. Of 12 noncompleters, 10
quit the study and 2 were dropped for noncooperation; they are combined because
they have in common that they were unwilling to participate in the study as required.
Table 2 presents only comparisons which were significantly different; there were no
significant differences among any oftheother questionnaire or demographic data dis-
cussed above.
Many more noncompleters were on lithium and they were significantly younger
than the completers. With respect to information and attitudes about the experi-
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TABLE 2
Comparisons ofCompleters and Noncompleters
Number and percentage
ofeach category Statistics
Mean age(yr) Completers Noncompleters t(56) = 2.98,
Categories 19.4 (N = 46) 17.9 (N = 12) P = 0.005
Drug received
Lithium (N = 35) 24 (68.6) 11 (31.4) x2(l) = 4.07, P = 0.044
Placebo (N = 21) 20 (95.2) 1 (4.76)
Nameofdrug tested
Correct (56) 46 (82.1) 10 (17.9) x2 (1) = 3.72, P = 0.054
Incorrect (2) 0 (0) 2 (100)
Drugs involved in study
Both correct (43) 35 (81.4) 8 (18.6) x2 (2) = 6.46, P = 0.040
One correct (6) 6 (100) 0 (0)
None correct (5) 2 (40.0) 3 (60.0)
Harmed by program?
Yes(14) 6(42.9) 8(57.1) x2(2)= 14.65,P<0.001
No (41) 37 (90.2) 4 (9.76)
? (2) 2 (100) 0 (0)
ment, the groups were similar. However, 67% ofthenoncompleters reported that the
program did them some harm, compared to 13% ofthe completers.
In 212years, 159 individuals were referred to the study, ofwhom 101 joined. Fifty-
three subjects completed the entire study and 14 completed at least 1 month on
medication. A total of 18 subjects quit, 14 while on medication and 4 before receiving
it. Six subjects were dropped for various reasons. The subjects who quit gave these
reasons: side effects (N = 10), disliked study procedures (N = 3), suspicious of staff
(N = 2), no reason available (N = 3). Twenty-five of the original referrals were
unsuitable and 14 others refused to participate in the experiment in any way. The
subjects who refused to participate gave these reasons: disliked any kind of medica-
tion (N = 4), not interested (N = 3), refused being "guinea pigs" (N = 2), disliked
blood samples (N = 1), felt study was not appropriate for him (N = 1). Finally, a few
subjects showed impatience and disinterest during the presentation of the study or
the explanation ofthe consent form.
DISCUSSION
We administered the questionnaire to the subjects when they terminated, usually 4
months after they received detailed information about the experifment. We chose to
administer the questionnaire at that time in order to get candid appraisals of the
study. Because the subjects were not questioned when they signed the consent form,
we cannot conclude how much they knew about the experiment at that time, al-
though it seems likely that questioning them shortly after theoral presentation would
have resulted in ahigher percentageofcorrect answers on Questions 1-6 (Table 1).
We have defined the key aspects ofinformed consent as follows: A subject should
know he is participating in an experiment and understand its objects or goals; he
should understand the risks and benefits ofparticipation; and he should not be forced
to participate. In order to evaluate the success ofinformed consent, we will deal with
information, coercion, and motivation separately.
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Information
With respect to information, Questions 1, 2, and 6 (Table 1) deal with the experi-
mental nature of the study, the drug being tested, the use of a placebo, and the object
of the experiment. Table 1 shows that over two-thirds of the subjects correctly
answered each of these questions, with the exception that only one-half specifically
indicated aggressive behavior in their answers. As discussed in Results, the im-
portance of aggressive behavior was so explicit in the study and widely known at the
institution that it is unlikely that only halfofthe subjects were aware ofit.
With respect to risks and benefits, Question 3 gives the principal benefit (payment)
and Question 5, the risk (side effects). Virtually all subjects correctly described pay-
ment, and two-thirds could identify at least one side effect described in the informa-
tional presentation. In addition, nearly two-thirds correctly described the reason for
the blood sample, which is related to risks ofparticipation.
Based on the results above, we conclude that approximately two-thirds of the sub-
jects had the information necessary for an informed consent to our experiment at the
timeoftesting.
Apparent lack of information was evident in several areas. Of 17 subjects (29%)
who did not correctly answer Question 2, 8 reported that they had no understanding
of the purpose of the study and 9 did not indicate its experimental nature. One-third
of the subjects gave no correct lithium side effects and did not give a correct explana-
tion for the blood samples. Thus, approximately one-third had inadequate informa-
tion on the nature and purpose ofthe study and on risk at the time oftesting.
It is possible that the subjects would have been better informed if we employed a
second presentation of key aspects of the study. This could have been accomplished
by administering Questions 1-6 to each subject before he started medication, giving a
second explanation of all questions the subject answered incorrectly. This procedure
would help insure that no subject received medication without understanding the key
aspects ofthe experiment, although no formal presentation can guarantee that a sub-
ject will employ the information in reaching a decision to participate.
Coercion
Even if adequately informed, a subject cannot make a free consent if coerced by
threats to his safety, quality oflife, or parole or release possibilities. We found no in-
dication of systematic coercion or that the subjects perceived themselves as forced to
join the study. For example, 14 of the 159 individuals we interviewed (8.8%) refused
outright to participate. Since nearly 1 in 10 men refused any contact with the study,
the referrals obviously perceived and exercised freedom ofchoice tojoin. In addition,
98% ofthe subjects answered they did not "feel forced" to join the study (Question 8,
Table 1). The single subject who felt forced quit the program after 6 weeks on
medication (placebo). Because inmates were candid in their criticisms of coercion
and authority in the institution, and because the question was simple and direct, we
believe the subjects felt themselves free from external pressure to join the experi-
ment.
These results indicate substantial freedom from coercion to join, and they reflect
our efforts to avoid pressuring subjects and reflect noninterference by the jail
administration. However, some subjects may not have answered Question 8 honestly
because an affirmative answer was defended against or denied as a result ofa need to
maintain a tough self-image.
Freedom to terminate is important to self-esteem and to an ongoing free and in-
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formed consent. Of the 101 men who agreed to join the study, 18 quit and, ofthe 80
men who received medication, 16 (20%) quit and specified side effects or adverse
effects on behavior as their reasons. Since 1 out ofevery 5 men who took medication
not only perceived but exercised the option to quit, coercion, if present, was not im-
portant enough to override motives ofself-protection or comfort.
Motivation
An informed subject with a free choice tojoin or continue an experiment might be
so strongly motivated to achieve rewards contingent upon participation that need for
the rewards overrides considerations ofsafety. In prison, the most important motiva-
tions are early release, improved living conditions in a "research unit" (4), and
money.
With respect to release, only 3 subjects indicated parole considerations as their
motivation for joining the study. Because there was pressure to join self-help pro-
grams run by jail staff at the study institution in order to achieve favorable parole
evaluation, this is an important result. It demonstrates that a practice on noninvolve-
ment with the parole board can be made clear to, and be understood by, volunteer
subjects. This result is consistent with the conclusion ofWells (17), based on a review
of the literature on motives for volunteering among prisoners, that "relatively few
believe, popular misconceptions notwithstanding, that volunteering will enhance
parole possibilities."
Bach-Y-Rita (4) has pointed out that in some prisons experimental subjects
receive better treatment or enjoy better living conditions than other prisoners. Since
participation in the experiment had no effect on the prisoners' status in the institu-
tion, and since there was no "research unit," such factors played no part in our study.
Money was the most important motive indicated by the subjects (42%), and vir-
tually all subjects correctly described the payment schedule. We cannot evaluate the
extent to which money may have induced subjects to remain on the study against
their better judgment. We attempted to minimize this by paying all subjects; no one
was denied payment for his time for any reason. Further, ifsubjects chose, they were
paid on a monthly basis so there was no need to take medication or to complete the
experiment to order to earn some money. However, we paid inmates at a rate com-
parable to the best-payingjobs at thejail. Since most ofour subjects did not aspire to
or qualify for thesejobs, the rate of pay may have been very attractive. In addition,
the bonus may have been a strong inducement. Since 1 out of 5 subjects quit, such
monetary considerations clearly did notoverride subjects'judgment, however.
The only other important motivation forjoining was self-improvement (34% ofthe
reasons given). Since our program was experimental, we attempted to discourage
subjects from joining because they felt the medication or the staff could offer them
successful treatment. That one-third gave self-improvement as a motive may mean
that we failed, and the subjects expected benefits we could not validly offer.
However, closer examination suggests that the men giving self-improvement as an
answer were motivated by their own designs and were not misled by our presentation.
Twenty-two of the 57 subjects who answered Question 9 gave self-help as a motive.
Fifteen of these (68%) reported some benefits from the study compared to 17/35
(48.6%) who did not seek benefits (X2(l) = 1.39, N.S.). Since those who both sought
and perceived benefits from the study were evenly divided between lithium carbonate
and placebo (lithium, 8 subjects; placebo, 7), their benefits reflect their own motiva-
tion for self-improvement. Because many inmates were sincerely concerned about
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personal change and growth, it is not surprising that subjects indicated self-improve-
ment as a motivation forjoining the study. And, since most (84%) ofthe subjects felt
we were honest about the study, with only 7% indicating they felt us to be dishonest,
they did not feel that the experiment staffmisled them.
Benefits and Harm
Finally, we examine subjects' appraisals ofbenefits and harm. Over halfofthe sub-
jects reported some benefits; most gave increased self-control and self-knowledge.
Fully one-fourth ofthe subjects reported harm, usually from side effects. Ofthe sub-
jects who quit, virtually all received lithium carbonate and overwhelmingly reported
harm (side effects) when compared to the completers. While motivated to join pri-
marily by money, benefits were perceived in personal terms ofself-control orgrowth.
Risks were perceived as related specifically to drug effects. Two subjects were
unsure if the program had harmed them because they were not confident of our
assurance that there were no long-term consequences ofreceiving lithium carbonate.
CONCLUSIONS
The results presented above show that approximately two-thirds of the subjects
had sufficient information on the nature and purpose of the experiment and its risks
and benefits to make an informed consent at the time oftesting, 4 months after com-
mencement of the experiment; fully one-third, however, did not. As administered in
the "medium security" host institution, this study seems to have been relatively free
from coercion tojoin, or to remain on medication, as shown by the significant number
of men who refused to join, who reported that they had not felt forced to join, and
who exercised their option to quit, and as shown by the very small number who gave
parole as a consideration forjoining. Therefore, it was possible to achieve a free and
informed consent with a majority ofthe prisoners in our study.
Based on our evaluation of the questionnaire responses and our impressions during
the experiment, we are certain that an explanation of the consent form on one occa-
sion only would have been entirely inadequate for an informed consent. Some men
displayed indifference during our explanation of the study or consent form by inter-
rupting or asserting disinterest. In such cases, it may be the best policy to exclude
subjects willing to accept risk, but unwilling to understand it, since in such subjects
the informational requirement ofinformed consent cannot be met.
In order to insure that subjects have the information required for an informed
consent, a questionnaire of the type we employed could be made mandatory before
participation involving risk begins. Subjects incorrectly answering key questions
could then receive additional information or be excluded from the experiment. The
latter alternative requires that the investigator or advisory committee thoroughly
and fairly present the experiment, but neither drill nor induce the subject to cram for
the questionnaire.
We chose to question subjects at the end of their participation to evaluate what
they had in fact learned, rather than offering a pass-or-fail test which would evaluate,
at worst, what they could memorize without understanding. We feel that an evalua-
tion of key aspects ofinformed consent should be a part of every experiment involv-
ing risk to human subjects. Such an evaluation could serve to improve the educa-
tional routine, to identify coercive factors influencing subjects, and to provide the in-
formation needed to clarify the problems ofprisoner participation in research.
In order to minimize coercive pressures on subjects, experiments must bedesigned
from the outset so that they will not trap subjects (for example, by refusing payment
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ifa subject does not complete an experiment or by conducting an experiment in an in-
stitution in which the parole board considers participation in a medical experiment to
be particularly meritorious). Our evaluation of coercion and our experience at the
host institution suggest that the conditions for a free consent would be compromised
at an institution wherejail administration or staffview an experiment as part oftheir
correctional repertory or as useful for reasons ofsecurity.
An earnest effort to avoid coercion and to describe risks may appear to or actually
cause an unacceptable dropout rate which may pose a serious problem for the com-
pletion of a successful experiment. This may place pressures on the investigator to
reorder priorities in the study in order to maximize the number ofsubjects available.
Because of this problem, we believe experiments involving significant risk, and
requiring either long study periods or a large sample size relative to the institution's
population, should generally not be undertaken with incarcerated subjects.
Finally, the investigator must be familiar with the power structureofthehost insti-
tution and remain independent of it in order to minimize institution-based pressures
on research subjects.
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